Trial Profile
Ramosetron vs ondansetron for the prevention of postoperative vomiting in children receiving fentanyl as PCA following orthopaedic surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2013
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary) ; Ramosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 29 Aug 2013 New trial record